Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N1IL
|
|||
| Former ID |
DIB002996
|
|||
| Drug Name |
HG-1246
|
|||
| Synonyms |
FLJ32633 modulator (cancer), Human Genome Sciences; HCBP12 modulator (cancer), Human Genome Sciences; Human prostatic specific reductase modulator (cancer), Human Genome Sciences; PSDR1 modulator (cancer), Human Genome Sciences; RALR1 modulator (cancer), Human Genome Sciences; Retinal reductase 1 modulator (cancer), Human Genome Sciences; Retinol dehydrogenase 11 modulator (cancer), Human Genome Sciences; MDT-82 modulator (cancer), Human Genome Sciences; Prostate short-chain dehydrogenase/reductase 1 modulator (cancer), Human Genome Sciences
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Investigative | [1] | |
| Company |
Human Genome Sciences Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.